Market Cap 504.93M
Revenue (ttm) 233.80M
Net Income (ttm) -15.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.69%
Debt to Equity Ratio 1.24
Volume 2,096,200
Avg Vol 2,286,490
Day's Range N/A - N/A
Shares Out 200.37M
Stochastic %K 52%
Beta 1.62
Analysts Strong Sell
Price Target $4.67

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivat...

Industry: Medical Devices
Sector: Healthcare
Phone: 925 288 6000
Address:
1220 Concord Avenue, Suite 600, Concord, United States
N8LongShort
N8LongShort May. 11 at 11:48 AM
$CERS can we run for clean blood for hantavirus $XBI
0 · Reply
N8LongShort
N8LongShort May. 7 at 5:33 PM
$CERS she wants 5+
2 · Reply
DAKZ18
DAKZ18 May. 6 at 12:32 PM
$CERS don't lack here
0 · Reply
Zardiw
Zardiw May. 5 at 10:32 PM
Found Early: $SDOT - Up 91%% - DDAmanda Chart Similar early alerts: $UONE $CERS $PS Never miss another: https://DDAmanda.com #DDAmanda
0 · Reply
DAKZ18
DAKZ18 May. 5 at 2:46 PM
$CERS keeping eyes on this for 11 squeeze
0 · Reply
djwaite01
djwaite01 May. 5 at 1:54 PM
$CERS what did the orange clown do now? everything is crashing across the board
0 · Reply
JFais
JFais May. 4 at 7:44 PM
Discussions in Chat to start the week: $CERS- medical device/turnaround story, raised guidance in Q1. TAM increase w/ P3 readout in Q4 $CGEM devil's advocate on TCE's in autoimmune=higher bar for safety $IDYA- worth a look after "sell the news" reaction to pivotal mUM results
0 · Reply
capitalthinktank
capitalthinktank May. 4 at 3:55 PM
$CERS remains within a bullish structural framework, with recent price action reflecting consolidation rather than trend failure. Price continues to hold above key support, showing sustained underlying demand. Volume shows alternating contraction and mild expansion, typical of a consolidation phase. The moving average structure remains aligned, with price trading around short- to mid-term averages without breakdown. As long as support holds, the structure remains constructive. Overhead supply zones remain the key area to watch for directional expansion. Overall, this is still a consolidation within an ongoing uptrend, not a reversal setup. 👉If this helps, tap @capitalthinktank
1 · Reply
trademx71
trademx71 May. 4 at 3:02 PM
0 · Reply
N8LongShort
N8LongShort May. 4 at 2:54 PM
$CERS going to 5
0 · Reply
Latest News on CERS
Cerus management to meet with Craig-Hallum

2026-05-07T02:35:32.000Z - 6 days ago

Cerus management to meet with Craig-Hallum


Cerus upgraded to Buy from Neutral at BTIG

2026-05-01T12:43:03.000Z - 12 days ago

Cerus upgraded to Buy from Neutral at BTIG


Cerus Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 12 days ago

Cerus Earnings Call Transcript: Q1 2026


Cerus reports Q1 EPS (1c), consensus (4c)

2026-04-30T20:23:26.000Z - 12 days ago

Cerus reports Q1 EPS (1c), consensus (4c)


Cerus announces new, four-year supply agreement with EFS

2026-04-27T12:14:12.000Z - 16 days ago

Cerus announces new, four-year supply agreement with EFS


Cerus names Vivek Jayaraman as CEO

2026-03-16T20:12:13.000Z - 2 months ago

Cerus names Vivek Jayaraman as CEO


Cathie Wood’s ARK Investment buys 612K shares of Cerus today

2026-03-06T01:55:10.000Z - 2 months ago

Cathie Wood’s ARK Investment buys 612K shares of Cerus today


Cerus Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 10:30 AM EST - 2 months ago

Cerus Transcript: TD Cowen 46th Annual Health Care Conference


Cerus Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 2 months ago

Cerus Earnings Call Transcript: Q4 2025


Cerus reports Q4 EPS (1c), two estimates 0c

2026-03-02T21:06:15.000Z - 2 months ago

Cerus reports Q4 EPS (1c), two estimates 0c


Cerus backs FY26 product revenue view $224M-$228M

2026-03-02T21:05:10.000Z - 2 months ago

Cerus backs FY26 product revenue view $224M-$228M


Cerus reports preliminary Q4 revenue $57.8M, consensus $59.31M

2026-01-11T22:15:24.000Z - 4 months ago

Cerus reports preliminary Q4 revenue $57.8M, consensus $59.31M


Cerus sees FY26 product revenue $224M-$228M

2026-01-11T22:15:15.000Z - 4 months ago

Cerus sees FY26 product revenue $224M-$228M


Cerus Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 6 months ago

Cerus Earnings Call Transcript: Q3 2025


Cerus reports Q3 EPS 0c, two estimates (3c)

2025-11-06T21:18:18.000Z - 6 months ago

Cerus reports Q3 EPS 0c, two estimates (3c)


Cerus Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 10:55 AM EDT - 8 months ago

Cerus Transcript: Cantor Global Healthcare Conference 2025


Cerus Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 10 months ago

Cerus Earnings Call Transcript: Q2 2025


Cerus reports Q2 EPS (3c), consensus (2c)

2025-08-05T20:16:20.000Z - 10 months ago

Cerus reports Q2 EPS (3c), consensus (2c)


Cerus announces additional DoD award to advance hemorrhage care

2025-07-21T13:35:10.000Z - 10 months ago

Cerus announces additional DoD award to advance hemorrhage care


Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 13, 2025, 4:01 PM EDT - 11 months ago

Cerus Corporation Celebrates World Blood Donor Day 2025


Cerus Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q1 2025


Cerus Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 5, 2025, 11:10 AM EST - 1 year ago

Cerus Transcript: TD Cowen 45th Annual Healthcare Conference


Cerus Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Earnings Call Transcript: Q4 2024


Cerus Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 4:10 PM EST - 1 year ago

Cerus Transcript: Stifel 2024 Healthcare Conference


Cerus Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q3 2024


Cerus Transcript: Study Update

Oct 16, 2024, 5:00 PM EDT - 1 year ago

Cerus Transcript: Study Update


Cerus Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q2 2024


Cerus Corporation Celebrates World Blood Donor Day 2024

Jun 14, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2024


Cerus Earnings Call Transcript: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q1 2024


Cerus Transcript: TD Cowen 44th Annual Health Care Conference

Mar 6, 2024, 11:10 AM EST - 2 years ago

Cerus Transcript: TD Cowen 44th Annual Health Care Conference


Cerus Earnings Call Transcript: Q4 2023

Mar 5, 2024, 4:30 PM EST - 2 years ago

Cerus Earnings Call Transcript: Q4 2023


Cerus Earnings Call Transcript: Q3 2023

Nov 2, 2023, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q3 2023


N8LongShort
N8LongShort May. 11 at 11:48 AM
$CERS can we run for clean blood for hantavirus $XBI
0 · Reply
N8LongShort
N8LongShort May. 7 at 5:33 PM
$CERS she wants 5+
2 · Reply
DAKZ18
DAKZ18 May. 6 at 12:32 PM
$CERS don't lack here
0 · Reply
Zardiw
Zardiw May. 5 at 10:32 PM
Found Early: $SDOT - Up 91%% - DDAmanda Chart Similar early alerts: $UONE $CERS $PS Never miss another: https://DDAmanda.com #DDAmanda
0 · Reply
DAKZ18
DAKZ18 May. 5 at 2:46 PM
$CERS keeping eyes on this for 11 squeeze
0 · Reply
djwaite01
djwaite01 May. 5 at 1:54 PM
$CERS what did the orange clown do now? everything is crashing across the board
0 · Reply
JFais
JFais May. 4 at 7:44 PM
Discussions in Chat to start the week: $CERS- medical device/turnaround story, raised guidance in Q1. TAM increase w/ P3 readout in Q4 $CGEM devil's advocate on TCE's in autoimmune=higher bar for safety $IDYA- worth a look after "sell the news" reaction to pivotal mUM results
0 · Reply
capitalthinktank
capitalthinktank May. 4 at 3:55 PM
$CERS remains within a bullish structural framework, with recent price action reflecting consolidation rather than trend failure. Price continues to hold above key support, showing sustained underlying demand. Volume shows alternating contraction and mild expansion, typical of a consolidation phase. The moving average structure remains aligned, with price trading around short- to mid-term averages without breakdown. As long as support holds, the structure remains constructive. Overhead supply zones remain the key area to watch for directional expansion. Overall, this is still a consolidation within an ongoing uptrend, not a reversal setup. 👉If this helps, tap @capitalthinktank
1 · Reply
trademx71
trademx71 May. 4 at 3:02 PM
0 · Reply
N8LongShort
N8LongShort May. 4 at 2:54 PM
$CERS going to 5
0 · Reply
DAKZ18
DAKZ18 May. 4 at 1:58 PM
$CERS adios
0 · Reply
DAKZ18
DAKZ18 May. 4 at 6:57 AM
$CERS watch this dip, over 2.8 could send us
0 · Reply
DavidScott
DavidScott May. 4 at 4:14 AM
On watch tomorrow (momentum) // Part 1 🔥📈📚 $SOBR $LABT $STAK $CERS $CUE
0 · Reply
SadyK189
SadyK189 May. 4 at 2:36 AM
Top Stocks to watch next week 2 / 2: $CERS $BRLS $XNDU $PN $ATOM.X CERS: Looking good on 4hours chart. Key support at 2 - 2.25. Next key level to test 3.15 - 3.40. Currently at 2.68 ATOM is trending nicely on daily chart. Key support at 9.2 - 9.65. Next key level to test 12.15 - 12.7. Currently at 10.89 BRLS: Getting up on 4hours chart. Key support at 1.25 - 1.40. Next key level to test 2.10 - 2.30. Currently at 1.66 XNDU: Trendingly nicely on daily chart. 26.7 - 28.3 is acting as key support zone. Next key level to test 40.2 - 41.5. Currently at 35.6 PN: Good close of 4hours candle. Key support at 3.8 - 4.1. Next key level to test 5.75 - 6. Currrently at 5.
0 · Reply
Mungman
Mungman May. 3 at 5:01 PM
$CERS Im keeping my eyes on this up and cummer. Bought some Friday, could be a nice Fliperouski
0 · Reply
TonySuprano
TonySuprano May. 2 at 10:59 PM
$CERS going to print
0 · Reply
DayTrade_4Life
DayTrade_4Life May. 2 at 5:41 PM
PROBLEM = Profitability; SOLUTION = Day Trade for Life 👉FROM WEEKLY WATCHLIST 27 Apr to 1 May: AKAN: $12 to 78.90 (557%) ATOM.X: 7.55 to 11.15 (47%) SCNI: Never hit entry 💵FROM 1 MAY WATCHLIST & ALERTS: AIOS: 11.25 to 33.87 (201%) SOBR: .68 to 1.26 (85%) CUE: 24.50 to 38 (55%) $XXII: 2.50 to 3.55 (42%) $TLIH: 3.25 to 4.61 (41%) AKAN: $56 to $78.90 (40%) $LABT: 3.75 to 4.65 (24%) $CERS: 2.55 to 3.15 (23%) $LRHC: 2.50 to 2.83 (13%)
0 · Reply
BullishVector
BullishVector May. 2 at 4:33 PM
Monday's top watch 5/4: $AMS $LNAI $CERS $ANGX $AKAN
1 · Reply
V2IcedPriate
V2IcedPriate May. 2 at 10:03 AM
$CERS Report this fucking spammer disgusting
0 · Reply
V2IcedPriate
V2IcedPriate May. 2 at 10:02 AM
0 · Reply